Shionogi Inc. Press Release: SHIONOGI RECEIVES FDA APPROVAL FOR OSPHENA (OSPEMIFENE) FOR THE TREATMENT OF DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL ATROPHY (VVA), DUE TO MENOPAUSE